India Trade & Investment Brief

Manufacture in India.
Sell to the world.

Ten priority sectors for foreign direct investment — five already backed by $25.3 billion in committed government incentives, five more ground-floor or newly mapped — each with a specific target FDI-source country, inside a $776 billion import market that's still growing faster than India can supply it.

$776.0bn
FY2025-26 import market
$25.3bn
PLI outlay, 14 sectors
+7%
GDP growth, FY2025-26
01 / 23
The Opportunity

A $776bn import market that outgrew its own supply base

India's imports grew nearly six times faster than its exports over the last five fiscal years — the exact gap that import-substitution manufacturing investment is built to close.

Merchandise Imports, FY25-26
$776.0bn
+26.6% over 5 years — the demand base for local manufacturing
Merchandise Exports, FY25-26
$441.7bn
+4.7% over 5 years — India as a re-export & assembly base
Import / Export Growth Ratio
5.7×
The capacity gap this deck's sectors are built to close

For an investor, that gap is the pitch: India already buys these goods from somewhere. The question is whether they get made in India, with a government actively subsidizing the transition through Production Linked Incentive (PLI) schemes.

02 / 23
Why Now

A government actively de-risking the first mover

836
PLI applications approved
Across 14 sectors as of Dec 2025, $3.69bn already disbursed, 14.39 lakh jobs created.
+75.6%
Services surplus growth, 5yr
A structurally strong external balance — India can absorb a larger goods deficit while it builds capacity.
96.37
₹/US$, 17 Jul 2026
A weaker rupee lowers dollar-denominated setup costs and improves export-side margins for a new plant.

This isn't a generic "India is growing" pitch. It's five specific sectors where a scheme is already funded, a supply gap is already measured, and — where relevant — an export channel to the US, EU, or Gulf already exists.

03 / 23
SECTOR 01

Electronics & Semiconductor Manufacturing

HS84–85 · India's single largest and fastest-growing high-tech import chapter — and the one chapter where policy support is already the strongest in the whole ledger.

Import value, FY25-26
$104.9bn
8-year growth
+101.5%
Export growth (same chapter)
+324.1%
Policy backing

India Semiconductor Mission 2.0 ($9.43bn) plus PLI Electronics/Mobile/Telecom — the strongest-matched chapter on either side of India's trade ledger. Currently 62% import-dependent on China for components: the exact capacity gap a new fab or assembly plant fills directly.

The investment case: government co-funding already committed, a domestic demand base of $104.9bn/year, and a proven re-export channel — this same chapter is India's fastest-growing export line too.

04 / 23
SECTOR 02

Specialty Steel & Metals

HS72–73 · The rare chapter matched on both the import-substitution and export-growth sides of the same ledger.

PLI Committed (1.0/1.1 + 1.2)
$6.9bn
period-matched conversion — one of the largest single PLI levers
Production Target, FY26-27
42 Mt
explicitly sized to cut import dependency
Export Value, Both Chapters
$20.7bn
HS72 + HS73 combined, FY2025-26

Round 1.2 alone: 85 projects, 55 companies, $1.40 billion, 8.7 million tonnes of new capacity, MoUs signed February 2026. Genuine white space remains for capacity beyond what's already been awarded — India still imports $15.8bn of iron & steel a year.

05 / 23
SECTOR 03

Auto, EV & Battery Storage

HS87 · A budget that nearly tripled in one year, and an export base already reaching five continents.

PLI Auto, FY26-27 budget
$701.4M
FY25-26 budget (prior year)
$247.0M
Vehicle export growth, 8yr
+43.5%
Established export lanes

USA, Mexico, South Africa, Saudi Arabia, UAE — already India's top-5 vehicle export destinations. The complementary ACC Battery Storage PLI ($2.25 billion, 50 GWh target, 40 GWh already awarded) feeds the same EV value chain.

The investment case: the fastest-scaling PLI budget in this deck, a market already exporting to 5 continents, and battery-storage capacity being built out in parallel.

06 / 23
SECTOR 04

Pharmaceuticals & Bulk Drug APIs

HS29/30 · India already leads the world in generic medicines. The gap is upstream — active pharmaceutical ingredients.

India Pharma + API Exports
$35.8bn
vs. ~$1.3 trillion in global demand (NITI Aayog, 2025) — vast headroom
PLI Bulk Drugs
$840.1M
48 projects selected, 34 already commissioned
Imports Avoided So Far
$179.5M
directly attributable to the scheme's early cohort

India remains roughly 70% dependent on China for API raw materials — the precise dependency this scheme targets. Telangana, Gujarat and Maharashtra are the established manufacturing clusters, with global-standard regulatory infrastructure already in place.

07 / 23
SECTOR 05

White Goods Components

AC compressors, copper tubes, aluminium foils (HS84) · A fully-subscribed scheme with a long committed production runway still to fill.

Companies Selected
85 / 85
all four selection rounds complete — a mature, de-risked scheme
Committed Investment
$1.39bn
4-6% incentive on incremental sales through FY2028-29
Cumulative Production Target
$23.58bn
the demand runway component suppliers are building against

The investment case: this scheme is closed to new PLI applicants, but that's the point — it signals a mature, proven supply chain a component manufacturer or Tier-2 supplier can plug into today, backed by a production target that runs to 2029.

08 / 23
SECTOR 06

Medical Devices

HS90 (subset) · A partial PLI window with three distinct, already-active FDI relationships to build on.

PLI Medical Devices Outlay
Rs 3,420cr
a partial scheme — real headroom remains beyond current coverage
Siemens Healthineers (Germany)
€160M
the sector's reference investment, in production under the PLI umbrella
Medtronic + GE-Wipro JV (USA)
$350M +
Rs 8,000cr
the two largest live US commitments in the sector

Japan adds a fourth track: Olympus's R&D center plus a new government-to-government research mechanism (the AMED-ICMR Memorandum of Cooperation, Aug 2025) — the same kind of treaty-level channel already working for Electronics and Auto/EV/Battery above.

09 / 23
Who To Court, Sector By Sector

Ten sectors, ten sourced country strategies — including one honest "no"

01 Electronics & Semiconductors
Taiwan (process tech) · Japan (IJICP) · USA (iCET/TRUST equipment)
02 Specialty Steel & Metals
Japan (JFE tech + Nashik) · Korea (POSCO-JSW $7.73bn)
03 Auto, EV & Battery
Korea (LGES-JSW, Agratas equipment) · Japan (Toyota $1.9bn, Suzuki)
04 Pharma & Bulk Drug APIs
USA (BIOSECURE-driven CDMO shift, Eli Lilly $1bn)
05 White Goods Components
Japan (Daikin, Nidec) · Korea (Samsung, LG) · Denmark (Danfoss)
06 Medical Devices
Germany (Siemens Healthineers) · Japan (Olympus) · USA (Medtronic)
07 Inorganic Chemicals
Japan (Sumitomo, Mitsubishi Gas Chemical) · Germany (Lanxess, directional)
08 Plastics
Saudi Arabia & UAE ($44bn RRPCL, MOU-stage) · Qatar · Japan
09 Aircraft & Spacecraft
France (Tata-Airbus C295, operating) · USA (Boeing, Lockheed) · Israel (IAI)
10 Textiles & Apparel (cotton)
No FDI-source country found. Real capital is Indian-owned, reshoring from Bangladesh. Fix is broadening PLI Textiles' scope, not a country pitch.
10 / 23
A Frame For India's Newest Tool

Reading the quota, not just the tariff

India is starting to pair tariffs with volume quotas — a distinct instrument with its own game theory.

The model

Passacantando & Raciti (2025) frame a tariff-rate quota as a Generalized Nash Equilibrium: several exporting firms compete for access to several importing countries, each setting a two-tier duty — low below a volume threshold, high above it. Because the quota is shared, one firm's access depends on how much the others take.

Journal of Dynamics and Games, Apr 2025 · DOI 10.3934/jdg.2025011

India's live case — AC compressor QCO, May 2026

Import volumes capped at 30-40% of FY2025 levels. Stated government intent: China's GMCC (the dominant global maker) "cannot sell into India unless they build factories in India."

A quota is a harder wall than a tariff — a firm can't pay its way past it. The model predicts exactly this: build in India, or cede share to whoever can operate inside the cap.

Worth knowing before targeting Japan/Korea for Specialty Steel (sector 02): India's own steel safeguard duty (through 2028) names both countries. Read through this model, that's not a contradiction — the duty is the mechanism pushing their capacity into Indian joint ventures rather than continued arm's-length exports.

11 / 23
Confirmed Actions Only — No Speculation

The official tariff timeline, 2025 to present

20 Feb 2026
US Supreme Court strikes down the entire IEEPA reciprocal-tariff regime — every India-specific rate issued under it is voided.
20 Feb 2026 →
Replaced with a flat global 10% Section 122 surcharge — not India-specific, capped by statute.
24 Jul 2026
The flat 10% surcharge is due to expire by statutory limit — the single most consequential near-term date in the current picture.
Pending
A proposed 12.5% Section 301 tariff naming India as the intended replacement — comment period closed 6 Jul 2026, not yet in force.
In force
Section 232: 50% steel/aluminum (global) · 25% semiconductors (AI chips only) · 100% patented pharma — generics/biosimilars excluded.
1 Jan 2026
EU CBAM definitive period begins on schedule — directly exposes ~$20.7bn of India's steel exports (see risk slide).

Because the whole 2025 reciprocal-tariff schedule was voided, the "India lost out to Vietnam/Bangladesh on tariffs" story is currently moot — all three now face the same flat 10%. And per NITI Aayog's own Trade Watch: China+1 diversification has had "limited success so far" for India — Vietnam, Thailand, Cambodia and Malaysia have captured more of the shift.

12 / 23
Beyond Central PLI

States are competing hard on top of central incentives

Every sector in this deck gets a state-level top-up — capital subsidy, SGST reimbursement, land and power concessions — layered on the central PLI figures already shown.

01 Electronics & Semiconductors
Gujarat tops up central ISM subsidy by 40% (~70% total capex support); Uttar Pradesh adds 50% on top (Tarq Semiconductors: Rs 7,037cr capital subsidy awarded)
02 Specialty Steel & Metals
Odisha: 20-30% capital subsidy + a mining-lease linkage reserving 50-80% of iron ore for state-based steelmakers; Chhattisgarh: rebate ceiling raised to 150% of investment for sponge-iron/steel
03 Auto, EV & Battery
Tamil Nadu: 100% SGST reimbursement for 15 years; Uttar Pradesh: 30% capital subsidy (capped Rs 1,000cr) for the first 2 ultra-mega battery/EV projects
04 Pharma & Bulk Drug APIs
Telangana's new Next-Gen Life Sciences Policy 2026-30 targets $25bn investment; Gujarat's Biotechnology Policy adds up to 25% capital subsidy on top of the general 12%
05 White Goods Components
Andhra Pradesh's Electronics Policy 4.0: 20-30% capital subsidy by project scale; Tamil Nadu: 15-30% by district, with "Consumer Electronics and Appliances" explicitly named a priority sub-sector
13 / 23
Where It's Already Landing

Real state hubs, with the evidence behind each one

Not just incentive policy on paper — named capital already committed, sector by sector.

Electronics — Gujarat & Assam
Micron's $2.75B ATMP at Sanand (commercial production Feb 2026); Tata Electronics-PSMC's Rs 91,000cr fab at Dholera; Tata's Rs 27,000cr ATMP at Jagiroad, Assam
Steel — Odisha & Karnataka
Odisha's Kalinganagar complex (Tata Steel expanding 3→8 Mt, Rs 47,599cr) plus 10 more mega plants worth over Rs 4 lakh crore; Karnataka's JSW Vijayanagar (12 MTPA, India's largest single-location plant)
Auto/EV/Battery — Tamil Nadu & Gujarat
Tamil Nadu's Chennai corridor makes 45% of India's automobiles; Gujarat's Tata Agratas 20 GWh battery gigafactory and Reliance's Jamnagar 40 GWh battery gigafactory (both targeting 2026)
Pharma APIs — Telangana & Gujarat
Telangana's Genome Valley: 200+ companies incl. Novartis, GSK, Dr. Reddy's; Gujarat: ~28-33% of India's drug manufacturing by volume, 130 USFDA-certified facilities
White Goods — Andhra Pradesh
Sri City already makes roughly half of India's ACs; LG's third India plant (~$600M, targeting end-2026) and the Daikin-Rechi compressor JV are both sited there
Two things worth knowing before you pick a state: West Bengal legislatively revoked every industrial incentive it had in 2025. Hyderabad's flagship Pharma City project currently has its land acquisition under a Telangana High Court stay. Full sourcing: state & central incentives bulletin.
14 / 23
GROUND FLOOR

Three sectors, no PLI yet — no incumbent to out-compete

Real, growing, unmet demand — with no Production Linked Incentive scheme in place. The first credible entrant sets the terms.

Inorganic Chemicals
HS28
$14.2bn
import value, growing +86.0% over 8 years
Plastics
HS39
$22.2bn
import value, growing +45.8% over 8 years
Aircraft & Spacecraft
HS88
$13.8bn
import value, growing +80.9% over 8 years

These are the cleanest import-substitution candidates this analysis found: real value, real growth, and — unlike the five sectors above — no existing scheme or funded competitor to negotiate around.

15 / 23
Route To Market

Manufacture here, and the export channel already exists

India's fastest-growing export chapters already reach the world's largest buyers — a new plant inherits the channel, not just the domestic market.

USA
$63.9bn
UAE
$26.9bn
Netherlands
$12.6bn
United Kingdom
$7.4bn
Combined export exposure by destination, top 12 growth chapters

The USA alone is the top-8 destination in 11 of India's 12 fastest-growing export chapters. That's an established, deep buyer relationship a new manufacturer can sell into from day one — not a market that needs to be built from scratch.

16 / 23
Read Before You Wire

Two risks worth pricing in, honestly

An investment case is only credible if it names its own risks. Both below are real, quantified, and manageable — not reasons to pass, reasons to structure around.

Carbon Border Risk (CBAM)
$20.7bn

of India's steel exports (HS72/73) sit inside the EU Carbon Border Adjustment Mechanism's initial scope. Specialty Steel PLI scales production; it doesn't by itself address the carbon-cost exposure. Structure for it: pair new capacity with lower-emissions production routes from day one.

Currency Volatility
+11.9%

rupee depreciation in the 12 months to July 2026 — faster than the prior decade's ~3.3%/year average. Favorable for dollar-cost setup and export margins now; underwrite financing assumptions against continued volatility, not the current spot rate alone.

Full sourcing and methodology: herrrickshaw.github.io/india-trade-sector-policy-recommendations

17 / 23
The Scorecard

Where PLI became real capital, sector by sector

Real DPIIT/RBI FDI-equity inflow tested against every scheme's launch date — not the government's self-reported "committed investment" figures. 2 green, 5 amber, 3 red.

Electronics & Semis
FDI +352%, moves opposite the national cycle
Medical Devices
FDI ~4x baseline, cleanest positive result
Specialty Steel
Real capacity, but domestic capital — FDI channel hasn't converted
Auto, EV & Battery
Gigafactories real, but Tata/Reliance capital — not FDI
Pharma & APIs
Rose, but timing points to COVID reshoring, not PLI
White Goods
Full subscription only Jan 2026 — too early to call
Aircraft & Spacecraft
No scheme, but the mildest FDI decline of any control sector
Inorganic Chemicals
No scheme, FDI −46.5% — the clearest "needs a first mover" case
Plastics
FDI −58.8%, worst trend in this scorecard; $44bn deal stuck at MOU
Textiles & Apparel
PLI/product mismatch, no FDI-source country identified

Methodology note: state-wise FDI data is attributed by a company's registered office, not its factory location — proven directly via a Jio Platforms/Gujarat case that predates the Semiconductor Policy by two years. Full sourcing: master sector scorecard.

18 / 23
The Financing Question

Why some states self-fund, and others need FDI

India's domestic capital isn't one price — benchmarked against 9 target countries' central bank rates, all below India's own.

India's two-tier cost of capital
RBI repo rate
5.25%
AAA bonds (Tata/Reliance)
7.4-8.3%
Ordinary borrower (EBLR)
9.5-10.5%

67.6% of the banking system's floating-rate book is now EBLR-priced — but AAA conglomerates bypass banks entirely, borrowing 100-250+ bps cheaper via bonds.

Every target country's rate sits below India's 5.25%
Japan1.00%
Taiwan2.00%
Eurozone (Germany)2.25%
South Korea2.75%
USA3.5-3.75%
Saudi Arabia4.25%
Domestic capital states

Assam, Odisha, Gujarat (battery), Karnataka — strategic capacity + AAA-tier bond access, no foreign IP dependency.

FDI states

Andhra Pradesh, Maharashtra, Tamil Nadu (compressors) — foreign-owned technology, no domestic incumbent to license from.

Honest caveat: cross-checked against ICRA's own sector-risk notes, this holds unevenly — strong for Defence, explicitly absent for Steel. Full analysis: domestic vs. FDI capital case.
19 / 23
The Living Scorecard

Re-run on FY2025-26 data: the verdicts moved

This analysis refreshes when the data does. FY2025-26 FDI closed at $58.8bn (+18%) — and against that rising cycle, three sector verdicts changed. New mix: 1 green · 6 amber · 3 red.

Electronics & Semis
−43.5%

green → amber. FDI nearly halved while the national cycle rose 18%. Landed capacity is real — but increasingly domestic-funded.

Medical Devices
−40.4%

green → amber. The concentration risk the original verdict itself flagged — a few MNC deals carrying the rise — materialized.

Pharma & Bulk Drug APIs
+114%

amber → green. Doubled to the series' highest level — landing after ₹5,433cr of disbursement, so the "it was just COVID reshoring" objection is now materially weaker.

The export half is working

Electronics exports +324% (5yr) to $54bn; Vehicles +43.5%; steel articles +42.8%. The only declining export chapters are the cotton-apparel ones PLI structurally misses.

The import half isn't, yet

Electronics imports also doubled — +101.5% to $104.9bn — the input side of the export boom. Component localization (ECMS) is where the deficit actually narrows.

Interactive version with slicers, growth-vs-volume analysis, and six ranked action items: FY2025-26 verdict re-run dashboard.
20 / 23
The Report Card

Does the incentive actually get paid? Grades, A to F

₹28,748cr disbursed across all 14 PLI sectors as of 31 Dec 2025 — roughly 15% of the outlay, verified against Parliament-answer PRIDs. For an investor, the grade below is the probability the scheme's money actually arrives.

A

Pharma (36% of outlay paid, sales ₹3.19 lakh cr) · Electronics (₹15,554cr paid, every target exceeded)

B

Medical Devices (₹157cr paid, 44 first-in-India products) · Telecom (~₹1,175cr paid, accelerating) · Food Processing · White Goods · Bulk Drugs (0.8% paid, outcomes real) · Solar PV (zero paid by design; 30 GW commissioned)

C

Drones (tiny scheme, did its job)

D

Auto (9.2% paid, accelerating) · Steel (0.8% paid; 14 of 58 projects withdrew) · Textiles (0.5% paid, to 2 unnamed companies)

F

ACC Battery — zero disbursed; 1 of 40 GWh in "pilot production" since Mar 2024, in PIB's own words

Who is actually producing (per PIB, release IDs cited): Micron, Kaynes and CG Semi shipping chips from Sanand · Foxconn and Dixon the first LSEM incentive recipients · 27 bulk-drug plants across 15+ named companies · Siemens Healthcare, Wipro GE and Philips making CT/MRI/coils in India. And a transparency tell: the underperforming schemes are also the anonymous ones — PIB names zero companies for Textiles, Steel and Food Processing.

Full graded table with evidence and PRIDs: PLI report card · IEM record: B+ (implementation ratio 109.9% in 2025) · Grades updated on Mar-2026 Lok Sabha replies — revisions shown, not hidden.
21 / 23
The Clearance Pipeline

What's actually coming: the environmental-clearance register

Between announcing a project and producing sits the gate that never lies: land acquired, Environmental Clearance obtained. India's full national EC register (113,804 proposals, state approvals included) is openly queryable — and it shows which states' investment surge has real pipeline behind it.

Industrial ECs: granted vs in-EIA (ToR)
Gujarat
1,049 + 836
Maharashtra
390 + 519
Odisha
280 + 83
Karnataka
220 + 175

Gujarat holds ~31% of all industrial EC grants plus the deepest forward pipeline. Maharashtra has more projects in EIA study than already cleared. Grant flow is accelerating: 198 → 734 → 1,102 per year.

Flagships in the register
Micron · Kaynes · Reliance electrolyser — EC granted
Tata fab (Dholera) · Tata ATMP (Assam) — in EIA (ToR)
All 3 Bulk Drug Parks · 3 of 7 PM MITRA parks — EC granted
Agratas 20 GWh gigafactory — in EIA (ToR)
The absences are due diligence

POSCO-JSW's $7.73bn steel JV: no EC application exists. RRPCL (~$44bn): absent from the register entirely. A project of scale with zero clearance activity is not being built — verifiable in one query.

For an investor this register is a free diligence tool: any Indian project's clearance reality is one API call away. Full state table, sector split and proposal numbers: EC pipeline bulletin.
22 / 23
Next Steps

Ten sectors, one window — while the incentive is still open

Electronics, Specialty Steel, Auto/EV/Battery, Pharma APIs, White Goods and Medical Devices carry funded government backing today. Inorganic Chemicals, Plastics and Aerospace remain open ground floor. Every sector above names a specific country to court — except Textiles, an honest "not yet."

Facilitation
Invest India
National Investment Promotion & Facilitation Agency
Policy
Ministry of Commerce & Industry
Department for Promotion of Industry and Internal Trade
Full Analysis
github.com/herrrickshaw
india-trade-sector-policy-recommendations
This deck is a derived analysis built from public TRADESTAT, RBI, and PIB/NITI Aayog data — not an official government publication or investment solicitation.